Literature DB >> 25808829

An infrared sensor analysing label-free the secondary structure of the Abeta peptide in presence of complex fluids.

Andreas Nabers1, Julian Ollesch1, Jonas Schartner1, Carsten Kötting1, Just Genius2, Ute Haußmann2, Hans Klafki2, Jens Wiltfang2,3, Klaus Gerwert4.   

Abstract

The secondary structure change of the Abeta peptide to beta-sheet was proposed as an early event in Alzheimer's disease. The transition may be used for diagnostics of this disease in an early state. We present an Attenuated Total Reflection (ATR) sensor modified with a specific antibody to extract minute amounts of Abeta peptide out of a complex fluid. Thereby, the Abeta peptide secondary structure was determined in its physiological aqueous environment by FTIR-difference-spectroscopy. The presented results open the door for label-free Alzheimer diagnostics in cerebrospinal fluid or blood. It can be extended to further neurodegenerative diseases. An immunologic ATR-FTIR sensor for Abeta peptide secondary structure analysis in complex fluids is presented.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  ATR-FTIR spectroscopy; Amyloid-beta; biosensor; body fluid; complex mixture; label-free; neurodegeneration; surface functionalization

Mesh:

Substances:

Year:  2015        PMID: 25808829     DOI: 10.1002/jbio.201400145

Source DB:  PubMed          Journal:  J Biophotonics        ISSN: 1864-063X            Impact factor:   3.207


  12 in total

1.  Spectroscopic Signature for Stable β-Amyloid Fibrils versus β-Sheet-Rich Oligomers.

Authors:  Justin P Lomont; Kacie L Rich; Michał Maj; Jia-Jung Ho; Joshua S Ostrander; Martin T Zanni
Journal:  J Phys Chem B       Date:  2017-12-27       Impact factor: 2.991

2.  The Effect of (-)-Epigallocatechin-3-Gallate on the Amyloid-β Secondary Structure.

Authors:  Atanu Acharya; Julia Stockmann; Léon Beyer; Till Rudack; Andreas Nabers; James C Gumbart; Klaus Gerwert; Victor S Batista
Journal:  Biophys J       Date:  2020-06-10       Impact factor: 4.033

3.  An ATR-FTIR Sensor Unraveling the Drug Intervention of Methylene Blue, Congo Red, and Berberine on Human Tau and Aβ.

Authors:  Jonas Schartner; Andreas Nabers; Brian Budde; Julia Lange; Nina Hoeck; Jens Wiltfang; Carsten Kötting; Klaus Gerwert
Journal:  ACS Med Chem Lett       Date:  2017-06-11       Impact factor: 4.345

4.  Monolayer Sensitivity Enables a 2D IR Spectroscopic Immuno-biosensor for Studying Protein Structures: Application to Amyloid Polymorphs.

Authors:  Joshua S Ostrander; Justin P Lomont; Kacie L Rich; Vivek Saraswat; Benjamin R Feingold; Megan K Petti; Erin R Birdsall; Michael S Arnold; Martin T Zanni
Journal:  J Phys Chem Lett       Date:  2019-06-27       Impact factor: 6.475

5.  Amyloid blood biomarker detects Alzheimer's disease.

Authors:  Andreas Nabers; Laura Perna; Julia Lange; Ute Mons; Jonas Schartner; Jörn Güldenhaupt; Kai-Uwe Saum; Shorena Janelidze; Bernd Holleczek; Dan Rujescu; Oskar Hansson; Klaus Gerwert; Hermann Brenner
Journal:  EMBO Mol Med       Date:  2018-05       Impact factor: 12.137

6.  Real-Time In Situ Secondary Structure Analysis of Protein Monolayer with Mid-Infrared Plasmonic Nanoantennas.

Authors:  Dordaneh Etezadi; John B Warner; Hilal A Lashuel; Hatice Altug
Journal:  ACS Sens       Date:  2018-06-12       Impact factor: 7.711

7.  Aβ and tau structure-based biomarkers for a blood- and CSF-based two-step recruitment strategy to identify patients with dementia due to Alzheimer's disease.

Authors:  Andreas Nabers; Henning Hafermann; Jens Wiltfang; Klaus Gerwert
Journal:  Alzheimers Dement (Amst)       Date:  2019-03-12

8.  Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer's Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis.

Authors:  Ann Tiiman; Vesna Jelić; Jüri Jarvet; Petter Järemo; Nenad Bogdanović; Rudolf Rigler; Lars Terenius; Astrid Gräslund; Vladana Vukojević
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

9.  Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline.

Authors:  Julia Stockmann; Inge M W Verberk; Charlotte E Teunissen; Klaus Gerwert; Nina Timmesfeld; Robin Denz; Brian Budde; Julia Lange-Leifhelm; Philip Scheltens; Wiesje M van der Flier; Andreas Nabers
Journal:  Alzheimers Res Ther       Date:  2020-12-24       Impact factor: 6.982

10.  Genetic predisposition, Aβ misfolding in blood plasma, and Alzheimer's disease.

Authors:  Hannah Stocker; Andreas Nabers; Laura Perna; Tobias Möllers; Dan Rujescu; Annette M Hartmann; Bernd Holleczek; Ben Schöttker; Julia Stockmann; Klaus Gerwert; Hermann Brenner
Journal:  Transl Psychiatry       Date:  2021-05-01       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.